Margaret Dugan
CIK: 0001909734
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Sep 15, 2026WHWK
Whitehawk Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
81.3K shares- - Sep 15, 2026WHWK
Whitehawk Therapeutics, Inc.
Award(A)DirectRestricted Stock Units
81.3K shares- - Jun 11, 2026ONC
BeOne Medicines Ltd.
Award(A)Direct19K shares- - May 22, 2026ONC
BeOne Medicines Ltd.
Sale(S)Direct212 shares at avg. $309.60$66K - May 14, 2026WHWK
Whitehawk Therapeutics, Inc.
Award(A)Direct19.1K shares at avg. $3.92$75K - Apr 1, 2026WHWK
Whitehawk Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
283.2K shares- - Dec 1, 2025WHWK
Whitehawk Therapeutics, Inc.
Award(A)DirectStock option (right to buy)
650K shares- - Dec 1, 2025WHWK
Whitehawk Therapeutics, Inc.
Award(A)DirectRestricted Stock Units
55.3K shares- - Oct 16, 2025SDGR
Schrodinger, Inc.
Sale(S)Direct1.4K shares at avg. $21.07$29K - May 21, 2025BGNE
BeiGene, Ltd.
Award(A)Direct11K shares- - Mar 3, 2025SDGR
Schrodinger, Inc.
Award(A)Direct12.5K shares- - Oct 15, 2024SDGR
Schrodinger, Inc.
Sale(S)Direct1.5K shares at avg. $17.78$27K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 |  WHWK Whitehawk Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 81,250 | - | - | Direct |
| Sep 15, 2026 | WHWK Whitehawk Therapeutics, Inc. | Award(A) Restricted Stock Units | 81,250 | - | - | Direct |
| Jun 11, 2026 |  ONC BeOne Medicines Ltd. | Award(A) | 18,980 | - | $0 | Direct |
| May 22, 2026 | ONC BeOne Medicines Ltd. | Sale(S) | 212 | $309.60 | $65,636 | Direct |
| May 14, 2026 | WHWK Whitehawk Therapeutics, Inc. | Award(A) | 19,132 | $3.92 | $74,997 | Direct |
| Apr 1, 2026 | WHWK Whitehawk Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 283,157 | - | - | Direct |
| Dec 1, 2025 | WHWK Whitehawk Therapeutics, Inc. | Award(A) Stock option (right to buy) | 650,000 | - | - | Direct |
| Dec 1, 2025 | WHWK Whitehawk Therapeutics, Inc. | Award(A) Restricted Stock Units | 55,309 | - | - | Direct |
| Oct 16, 2025 |  SDGR Schrodinger, Inc. | Sale(S) | 1,395 | $21.07 | $29,387 | Direct |
| May 21, 2025 |  BGNE BeiGene, Ltd. | Award(A) | 10,985 | - | - | Direct |
| Mar 3, 2025 | SDGR Schrodinger, Inc. | Award(A) | 12,500 | - | - | Direct |
| Oct 15, 2024 | SDGR Schrodinger, Inc. | Sale(S) | 1,531 | $17.78 | $27,226 | Direct |
1-12 of 12 transactions
About Dugan Margaret
Dugan Margaret (SEC CIK 0001909734) files insider reports with the SEC as Chief Medical Officer of Whitehawk Therapeutics, Inc. (WHWK), Director of BeOne Medicines Ltd. (ONC) and Chief Medical Officer of Schrodinger, Inc. (SDGR).
Signal8 holds 12 ownership filings by Dugan Margaret (1 Form 3, 11 Form 4), filed between Oct 16, 2024 and Sep 18, 2026. Those filings report 12 transactions, from Oct 15, 2024 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Dugan Margaret's filings is in MORRISTOWN, NJ.
Recent filings by Dugan Margaret
- Sep 15, 2026: Grants or awards of WHWK derivative securities (2 lines, Form 4, code A).
- Jun 11, 2026: Grant or award of ONC shares (Form 4, code A).
- May 22, 2026: Open-market sale of ONC shares (Form 4, code S).
- May 14, 2026: Grant or award of WHWK shares (Form 4, code A).
- Apr 1, 2026: Grant or award of WHWK derivative securities (Form 4, code A).
Other insiders filing for Whitehawk Therapeutics, Inc. (WHWK)
- Giacobello Scott M., CHIEF FINANCIAL OFFICER
- BALL BRYAN
- Dornan David, Chief Scientific Officer
- Lennon David James, CHIEF EXECUTIVE OFFICER
- Iyengar Vijay K, Director
- Dalal Anupam, Director